
Pharmaceuticals & Healthcare · NSE / BSE
Senores Pharmaceuticals Limited, incorporated on December 26, 2017, is an Ahmedabad-based pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded generic medicines for both domestic and global markets. Its diversified product portfolio spans key therapeutic areas, including gastrointestinal, cardiovascular, respiratory, pain management, and anti-infective segments. Driven by strong R&D capabilities, the company emphasizes innovation, cost-effective product development, and strict regulatory compliance. Senores operates through a robust distribution network supported by subsidiaries such as Ratnatris Pharmaceuticals Private Limited and Havix Group, Inc. (Aavis Pharmaceuticals). It serves customers across major international markets, including the US, Europe, and other emerging regions.
Price Band
₹372 – ₹391
Issue Size
₹582 Cr
Lot Size
38 shares
GMP
+72.6%
Est. Listing
₹675
at current GMP
Subscribed
97.25x
overall
Open
20 Dec 2024
Close
24 Dec 2024
Allotment
26 Dec 2024
Refund
27 Dec 2024
Demat Credit
28 Dec 2024
Listing
30 Dec 2024